Somatostatin-14 and -28: clearance and potency on gastric function in dogs.
To examine the significance of somatostatin-14 (S-14) and somatostatin-28 (S-28) in gastric physiology, we compared their relative potencies on acid secretion in the dog. On a molar infusion basis, S-14 and S-28 appeared to be equipotent, causing 50% inhibition of peptone meal-stimulated acid secretion at a dose of 400 pmol . kg-1 . h-1. However, comparison of the plasma half lives (t 1/2) of the two peptides revealed that S-28 disappeared at a much slower rate (t 1/2 = 2.84 +/- 0.15 min, mean +/- SE, n = 7) than S-14 (t 1/2 = 0.57 +/- 0.06 min). When acid-inhibitory effect was compared against increment in plasma concentrations produced by peptide infusion, S-14 was roughly 10-fold more potent than S-28. No alteration of gastrin response to peptone was observed at a dose of S-14 or S-28 that completely abolished acid secretion, suggesting that regulation of acid secretion is not mediated by gastrin inhibition. Thus, S-14 is a potent and possibly important physiological inhibitor of gastric acid secretion. Although circulating S-28 may have importance in regulation of some biological functions, it appears to play a less prominent role in regulation of gastric secretion.
D000818:Animals; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005744:Gastric Acid / Q000378:metabolism*; D005746:Gastric Emptying / Q000187:drug effects; D011863:Radioimmunoassay; D013004:Somatostatin / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D053561:Somatostatin-28; D013270:Stomach / Q000187:drug effects
D013004:Somatostatin; D053561:Somatostatin-28